6-CHLORO-1-ETHYL-2-METHYL-3-(3-SULFONATOPROPYL)-5-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOLIUM
UNII G8XMQ283Y8
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-chloro-1-ethyl-2-methyl-3-(3-sulfonatopropyl)-5-(trifluoromethyl)-1h-benzimidazolium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G8XMQ283Y8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 30377-68-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C14H16ClF3N2O3S FDUCVSFKFRCLCP-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-chloro-1-ethyl-2-methyl-3-(3-sulfonatopropyl)-5-(trifluoromethyl)-1h-benzimidazolium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.